![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TUBA1A |
Gene summary for TUBA1A |
![]() |
Gene information | Species | Human | Gene symbol | TUBA1A | Gene ID | 7846 |
Gene name | tubulin alpha 1a | |
Gene Alias | B-ALPHA-1 | |
Cytomap | 12q13.12 | |
Gene Type | protein-coding | GO ID | GO:0000226 | UniProtAcc | Q71U36 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7846 | TUBA1A | sample3 | Human | Cervix | CC | 2.78e-38 | -8.56e-01 | 0.1387 |
7846 | TUBA1A | H2 | Human | Cervix | HSIL_HPV | 3.00e-21 | -7.11e-01 | 0.0632 |
7846 | TUBA1A | L1 | Human | Cervix | CC | 2.16e-11 | -7.15e-01 | 0.0802 |
7846 | TUBA1A | T1 | Human | Cervix | CC | 7.46e-07 | -5.69e-01 | 0.0918 |
7846 | TUBA1A | T3 | Human | Cervix | CC | 1.93e-35 | -8.55e-01 | 0.1389 |
7846 | TUBA1A | AEH-subject1 | Human | Endometrium | AEH | 4.72e-06 | -3.65e-01 | -0.3059 |
7846 | TUBA1A | AEH-subject5 | Human | Endometrium | AEH | 7.18e-34 | -8.78e-01 | -0.2953 |
7846 | TUBA1A | EEC-subject1 | Human | Endometrium | EEC | 3.68e-05 | -4.19e-01 | -0.2682 |
7846 | TUBA1A | EEC-subject2 | Human | Endometrium | EEC | 1.06e-20 | -7.28e-01 | -0.2607 |
7846 | TUBA1A | EEC-subject3 | Human | Endometrium | EEC | 8.00e-30 | -6.90e-01 | -0.2525 |
7846 | TUBA1A | EEC-subject4 | Human | Endometrium | EEC | 4.09e-08 | -4.77e-01 | -0.2571 |
7846 | TUBA1A | EEC-subject5 | Human | Endometrium | EEC | 9.70e-28 | -7.98e-01 | -0.249 |
7846 | TUBA1A | GSM5276934 | Human | Endometrium | EEC | 1.45e-09 | 1.97e-01 | -0.0913 |
7846 | TUBA1A | GSM5276935 | Human | Endometrium | EEC | 1.70e-17 | -5.78e-01 | -0.123 |
7846 | TUBA1A | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 7.34e-22 | -7.01e-01 | -0.1869 |
7846 | TUBA1A | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 3.25e-26 | -8.30e-01 | -0.1875 |
7846 | TUBA1A | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 1.01e-29 | -7.45e-01 | -0.1883 |
7846 | TUBA1A | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 5.55e-31 | -7.10e-01 | -0.1934 |
7846 | TUBA1A | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 1.93e-38 | -6.81e-01 | -0.1917 |
7846 | TUBA1A | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 1.66e-45 | -9.21e-01 | -0.1916 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00307057 | Cervix | CC | cytoskeleton-dependent intracellular transport | 40/2311 | 195/18723 | 7.92e-04 | 6.99e-03 | 40 |
GO:003070513 | Cervix | N_HPV | cytoskeleton-dependent intracellular transport | 13/534 | 195/18723 | 4.03e-03 | 3.16e-02 | 13 |
GO:00307058 | Endometrium | AEH | cytoskeleton-dependent intracellular transport | 38/2100 | 195/18723 | 4.72e-04 | 4.91e-03 | 38 |
GO:00508086 | Endometrium | AEH | synapse organization | 67/2100 | 426/18723 | 2.67e-03 | 1.94e-02 | 67 |
GO:003070514 | Endometrium | EEC | cytoskeleton-dependent intracellular transport | 39/2168 | 195/18723 | 4.40e-04 | 4.58e-03 | 39 |
GO:005080812 | Endometrium | EEC | synapse organization | 68/2168 | 426/18723 | 3.73e-03 | 2.49e-02 | 68 |
GO:003070518 | Esophagus | ESCC | cytoskeleton-dependent intracellular transport | 133/8552 | 195/18723 | 1.48e-10 | 4.27e-09 | 133 |
GO:003070510 | Oral cavity | OSCC | cytoskeleton-dependent intracellular transport | 113/7305 | 195/18723 | 6.03e-08 | 1.09e-06 | 113 |
GO:003070516 | Oral cavity | LP | cytoskeleton-dependent intracellular transport | 68/4623 | 195/18723 | 8.92e-04 | 7.64e-03 | 68 |
GO:003070523 | Oral cavity | EOLP | cytoskeleton-dependent intracellular transport | 42/2218 | 195/18723 | 8.11e-05 | 9.69e-04 | 42 |
GO:003070531 | Oral cavity | NEOLP | cytoskeleton-dependent intracellular transport | 46/2005 | 195/18723 | 1.81e-07 | 6.18e-06 | 46 |
GO:00307059 | Prostate | BPH | cytoskeleton-dependent intracellular transport | 68/3107 | 195/18723 | 3.78e-10 | 1.98e-08 | 68 |
GO:00508087 | Prostate | BPH | synapse organization | 103/3107 | 426/18723 | 3.19e-05 | 3.61e-04 | 103 |
GO:00508072 | Prostate | BPH | regulation of synapse organization | 48/3107 | 211/18723 | 1.23e-02 | 4.94e-02 | 48 |
GO:003070515 | Prostate | Tumor | cytoskeleton-dependent intracellular transport | 67/3246 | 195/18723 | 6.56e-09 | 2.53e-07 | 67 |
GO:005080813 | Prostate | Tumor | synapse organization | 105/3246 | 426/18723 | 7.20e-05 | 7.62e-04 | 105 |
GO:005080711 | Prostate | Tumor | regulation of synapse organization | 50/3246 | 211/18723 | 1.11e-02 | 4.56e-02 | 50 |
GO:003070524 | Skin | cSCC | cytoskeleton-dependent intracellular transport | 77/4864 | 195/18723 | 2.32e-05 | 2.67e-04 | 77 |
GO:0030705111 | Thyroid | PTC | cytoskeleton-dependent intracellular transport | 104/5968 | 195/18723 | 3.87e-10 | 1.24e-08 | 104 |
GO:00508089 | Thyroid | PTC | synapse organization | 161/5968 | 426/18723 | 5.11e-03 | 2.36e-02 | 161 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501218 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502016 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501616 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0501016 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0501416 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502216 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0513218 | Breast | Precancer | Salmonella infection | 49/684 | 249/8465 | 2.92e-09 | 6.15e-08 | 4.71e-08 | 49 |
hsa0513018 | Breast | Precancer | Pathogenic Escherichia coli infection | 38/684 | 197/8465 | 3.12e-07 | 5.81e-06 | 4.45e-06 | 38 |
hsa0453018 | Breast | Precancer | Tight junction | 31/684 | 169/8465 | 1.13e-05 | 1.26e-04 | 9.64e-05 | 31 |
hsa0414518 | Breast | Precancer | Phagosome | 27/684 | 152/8465 | 7.37e-05 | 6.85e-04 | 5.25e-04 | 27 |
hsa042108 | Breast | Precancer | Apoptosis | 25/684 | 136/8465 | 7.61e-05 | 6.87e-04 | 5.26e-04 | 25 |
hsa0501219 | Breast | Precancer | Parkinson disease | 99/684 | 266/8465 | 3.58e-42 | 5.65e-40 | 4.33e-40 | 99 |
hsa0502017 | Breast | Precancer | Prion disease | 95/684 | 273/8465 | 1.39e-37 | 1.46e-35 | 1.12e-35 | 95 |
hsa0501617 | Breast | Precancer | Huntington disease | 98/684 | 306/8465 | 2.85e-35 | 2.25e-33 | 1.72e-33 | 98 |
hsa0501017 | Breast | Precancer | Alzheimer disease | 103/684 | 384/8465 | 1.03e-29 | 4.66e-28 | 3.57e-28 | 103 |
hsa0501417 | Breast | Precancer | Amyotrophic lateral sclerosis | 98/684 | 364/8465 | 2.13e-28 | 8.41e-27 | 6.44e-27 | 98 |
hsa0502217 | Breast | Precancer | Pathways of neurodegeneration - multiple diseases | 112/684 | 476/8465 | 6.96e-27 | 2.44e-25 | 1.87e-25 | 112 |
hsa0513219 | Breast | Precancer | Salmonella infection | 49/684 | 249/8465 | 2.92e-09 | 6.15e-08 | 4.71e-08 | 49 |
hsa0513019 | Breast | Precancer | Pathogenic Escherichia coli infection | 38/684 | 197/8465 | 3.12e-07 | 5.81e-06 | 4.45e-06 | 38 |
hsa0453019 | Breast | Precancer | Tight junction | 31/684 | 169/8465 | 1.13e-05 | 1.26e-04 | 9.64e-05 | 31 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TUBA1A | SNV | Missense_Mutation | c.156N>G | p.Phe52Leu | p.F52L | Q71U36 | protein_coding | deleterious_low_confidence(0.01) | benign(0.337) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
TUBA1A | SNV | Missense_Mutation | novel | c.547N>C | p.Glu183Gln | p.E183Q | Q71U36 | protein_coding | deleterious_low_confidence(0) | probably_damaging(1) | TCGA-B6-A3ZX-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | cyclophosphamide | PD |
TUBA1A | SNV | Missense_Mutation | c.167N>T | p.Thr56Met | p.T56M | Q71U36 | protein_coding | deleterious_low_confidence(0.02) | benign(0.305) | TCGA-E2-A1LS-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Cyclophosphamide | SD | |
TUBA1A | insertion | Nonsense_Mutation | novel | c.138_139insATTTGATGTCATTTTGTAAATGTTAATGAGAATTTTTTAAAA | p.Asp46_Asp47insIleTerCysHisPheValAsnValAsnGluAsnPheLeuLys | p.D46_D47insI*CHFVNVNENFLK | Q71U36 | protein_coding | TCGA-AN-A0FN-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
TUBA1A | SNV | Missense_Mutation | c.251N>A | p.Arg84His | p.R84H | Q71U36 | protein_coding | deleterious_low_confidence(0.02) | benign(0.009) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
TUBA1A | SNV | Missense_Mutation | rs1065730 | c.1339N>A | p.Glu447Lys | p.E447K | Q71U36 | protein_coding | deleterious_low_confidence(0.03) | benign(0.292) | TCGA-Q1-A73O-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
TUBA1A | SNV | Missense_Mutation | novel | c.826A>G | p.Ile276Val | p.I276V | Q71U36 | protein_coding | tolerated_low_confidence(0.2) | benign(0.015) | TCGA-A6-3809-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TUBA1A | SNV | Missense_Mutation | rs886039513 | c.367N>T | p.Arg123Cys | p.R123C | Q71U36 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.915) | TCGA-AU-6004-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TUBA1A | SNV | Missense_Mutation | novel | c.565N>A | p.Leu189Ile | p.L189I | Q71U36 | protein_coding | deleterious_low_confidence(0.01) | probably_damaging(0.922) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
TUBA1A | SNV | Missense_Mutation | c.959N>A | p.Arg320His | p.R320H | Q71U36 | protein_coding | deleterious_low_confidence(0.03) | possibly_damaging(0.454) | TCGA-G4-6304-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Chemotherapy | fluorouracil | PD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
7846 | TUBA1A | DRUGGABLE GENOME | MEBENDAZOLE | MEBENDAZOLE | ||
7846 | TUBA1A | DRUGGABLE GENOME | CHEMBL2108628 | PACLITAXEL POLIGLUMEX | ||
7846 | TUBA1A | DRUGGABLE GENOME | CHEMBL492399 | VERUBULIN | ||
7846 | TUBA1A | DRUGGABLE GENOME | inhibitor | CHEMBL378544 | VINBLASTINE SULFATE | |
7846 | TUBA1A | DRUGGABLE GENOME | CURCUMIN | CURCUMIN | 23830698 | |
7846 | TUBA1A | DRUGGABLE GENOME | ZAMPANOLIDE | ZAMPANOLIDE | 19877653 | |
7846 | TUBA1A | DRUGGABLE GENOME | VINORELBINE BASE | VINORELBINE | 25768699 | |
7846 | TUBA1A | DRUGGABLE GENOME | NSC-753575 | CHEMBL2036119 | 22543234 | |
7846 | TUBA1A | DRUGGABLE GENOME | COMBRETASTATIN A4 | COMBRETASTATIN A4 | 23631389,16913727,22543234,25584687,24669888,17765552,25192811 | |
7846 | TUBA1A | DRUGGABLE GENOME | inhibitor | CHEMBL1743082 | TRASTUZUMAB EMTANSINE |
Page: 1 2 3 4 5 |